C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2001
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2406829A1 Protease inhibitors
11/28/2001	EP1158358A2 Imaging element containing a blocked photographically useful compound
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157020A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments
11/28/2001	EP1157019A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
11/28/2001	EP1157011A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
11/28/2001	EP1157009A1 Dopamine d1 receptor agonist compounds
11/28/2001	EP1156807A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/28/2001	EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001	EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001	EP0690712B1 Taxanes having a pyridyl substituted side-chain
11/28/2001	CN1324355A Oxobenzofuranylide-dihydroindolone
11/28/2001	CN1324352A 2-phenylpyran-4-one derivatives
11/28/2001	CN1324250A Method for treating or preventing viral infections and associated diseases
11/27/2001	US6323228 3-substituted indole angiogenesis inhibitors
11/27/2001	US6323217 Cardiovascular disorders
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323211 Alpha.-adrenergic receptor antagonist and at least one compound that elevates endogenous nitric oxide or endothelium-derived relaxing factor in vivo
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087834A1 Melanin-concentrating hormone antagonist
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087826A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/22/2001	WO2001087806A2 Process for the preparation of aniline compounds
11/22/2001	WO2001087299A1 Aralkyl ester soft drugs
11/22/2001	WO2001087287A2 Use of pyrazole derivatives for treating infertility
11/22/2001	WO2001030752A3 Indole compounds for treating bacterial infections
11/22/2001	WO2001012607B1 Pharmaceutical compositions comprising 4-quinolones for treating cancers
11/22/2001	WO2001005769A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/22/2001	US20010044547 From l-mannonic-gamma-lactone intermediates; for prophylaxis of HIV/AIDS HIV
11/22/2001	US20010044537 Inhibit human factor Xa; treating thrombotic activity; 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-((2-(1,2 -dihydoxyethyl)-4-hydroxy-5-ethoxytetrahydrofuran-3-yl)oxy)-pyridin-2 -yl)oxy)4-hydroxybenzamidine
11/22/2001	US20010044536 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
11/22/2001	US20010044445 Azole inhibitors of cytokine production
11/22/2001	US20010044435 Antitumor agents, treatment of the lungs and respiratory tract
11/22/2001	DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2409445A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001	CA2409035A1 Hydroxamic acid derivatives
11/22/2001	CA2408913A1 Melanin-concentrating hormone antagonist
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	CA2407099A1 Aralkyl ester soft drugs
11/22/2001	CA2405507A1 Use of pyrazole derivatives for treating infertility
11/22/2001	CA2375065A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156043A2 Drugs that enhance synaptic responses mediated by ampa receptors
11/21/2001	EP1156040A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
11/21/2001	EP1156037A1 Chondrongenesis promotors and indolin-2-one derivatives
11/21/2001	EP1155695A1 1,3 oxathiolane nucleoside analogues
11/21/2001	EP1155016A1 Process for the production of paroxetine hydrochloride acetone solvate
11/21/2001	EP1155015A1 Process for the production of tert-butyl (e)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl](4r,6s)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
11/21/2001	EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP0931079B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0900207B1 Pyrazinone thrombin inhibitors
11/21/2001	EP0833827B1 2-amino-1,3,5-triazines, process for their preparation and their use as herbicides and plant-growth regulators
11/21/2001	EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001	EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001	EP0826684B1 Piperidine derivatives
11/21/2001	EP0719773B1 Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
11/21/2001	CN1323396A Endogenous constitutively activated G protein-coupled orphan receptors
11/21/2001	CN1323304A 2-hetaryl-3,4-dihydro-2h-pyrrole derivatives
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001	CN1323297A Pyridazinone derivatives
11/21/2001	CN1323295A AZA-bicycles which modulate the inhibition of cell adhesion
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1075070C Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
11/21/2001	CN1075067C Furan and furan amide compound and producing process and pharmaceutical composition thereof
11/21/2001	CN1074926C Antiarrhythmic benzodiazepines
11/21/2001	CN1074924C Preparing method for medical composition containing 1,3-oxathiolane nucleoside analogues
11/20/2001	US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001	US6320051 Amino(nh) or oxygen(o) substituted, enzyme inhibitors of staphloccocus aureus methionyl t-rna synthetase (mrs); antibacterial agents
11/20/2001	US6320040 Preparing novel nucleoside oligomers bearing pendant conjugate groups for incorporation into nucleic acids
11/20/2001	US6319939 Retinoic acid mimetic anlides
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001	US6319920 Muscarinic receptor antagonist used in gastrointestinal, genitourinary tract, respiratory tract, cardiovascular system, central nervous system disorders and in anesthesiology and ophthalmology
11/20/2001	US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/20/2001	CA2012507C Non-migrating 1-hydrocarbyloxy hindered amine compounds as polymer stabilizers
11/15/2001	WO2001085720A1 Novel anti-infectives
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	WO2001085716A1 2-piperidone compounds for the treatment of cancer
11/15/2001	WO2001085709A2 New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
11/15/2001	WO2001085705A1 Substituted n-benzoyl-n'-(tetrazolylphenyl)-ureas and their use as pest control agents
11/15/2001	WO2001085701A1 5-ht7 receptor antagonists
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085693A1 N-acyltetrahydroisoquinoline derivatives

1 ... 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 ... 694